Investigating how certain metabolites affect inflammation and energy failure in older adults with delirium

Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium

NIH-funded research Buck Institute for Research on Aging · NIH-11098994

This study is looking at how brain inflammation and energy problems might lead to confusion in older adults with Alzheimer's and similar conditions, and it’s exploring whether using ketone bodies can help boost brain energy and improve thinking skills to reduce confusion.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBuck Institute for Research on Aging NIH-funded
Lab location1 site (Novato, United States)
Project IDNIH-11098994 on NIH RePORTER

What this research studies

This research focuses on understanding delirium, a common condition in older adults characterized by confusion, particularly in those with Alzheimer's Disease and Related Dementias (ADRD). The study aims to explore the connection between neuroinflammation and energy disruption in the brain, using various methods including cell systems, mouse models, and human biospecimens. By examining how ketone bodies can serve as an alternative energy source for the brain, the research seeks to uncover potential therapeutic strategies to improve cognitive function and reduce the risk of delirium in older patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults, especially those diagnosed with Alzheimer's Disease or related dementias who are at risk for delirium.

Not a fit: Patients who are younger or do not have any cognitive impairments or risk factors for delirium may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help prevent or alleviate delirium in older adults, particularly those with Alzheimer's Disease.

How similar studies have performed: Previous research has shown promising results using ketogenic diets to improve cognitive function in aging models, suggesting potential success for this approach.

Where this research is happening

Novato, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.